Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)

NCT04456088 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated (halted prematurely)

Conditions

COVID-19
SARS-CoV 2
Respiratory Disease
Pneumonia, Viral
Corona Virus Infection

Interventions

COMBINATION_PRODUCT: 150 ppm Nitric Oxide delivered through LungFit Delivery System
COMBINATION_PRODUCT: 80 ppm Nitric Oxide delivered through LungFit Delivery System

Sponsor

Beyond Air Inc.